CN117126815A - 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 - Google Patents
用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 Download PDFInfo
- Publication number
- CN117126815A CN117126815A CN202310853662.2A CN202310853662A CN117126815A CN 117126815 A CN117126815 A CN 117126815A CN 202310853662 A CN202310853662 A CN 202310853662A CN 117126815 A CN117126815 A CN 117126815A
- Authority
- CN
- China
- Prior art keywords
- tobacco
- plant
- plants
- seq
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 877
- 244000061176 Nicotiana tabacum Species 0.000 title claims abstract description 841
- 238000000034 method Methods 0.000 title claims abstract description 139
- 230000002829 reductive effect Effects 0.000 title claims abstract description 90
- 239000000203 mixture Substances 0.000 title abstract description 20
- 230000001976 improved effect Effects 0.000 claims abstract description 108
- 241000208125 Nicotiana Species 0.000 claims abstract description 42
- 241000196324 Embryophyta Species 0.000 claims description 569
- 229920001184 polypeptide Polymers 0.000 claims description 183
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 183
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 183
- 150000007523 nucleic acids Chemical group 0.000 claims description 98
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 63
- 239000000463 material Substances 0.000 claims description 48
- 235000019505 tobacco product Nutrition 0.000 claims description 47
- 108700019146 Transgenes Proteins 0.000 claims description 46
- 235000019504 cigarettes Nutrition 0.000 claims description 27
- 239000000779 smoke Substances 0.000 claims description 22
- 108091026890 Coding region Proteins 0.000 claims description 17
- 230000001055 chewing effect Effects 0.000 claims description 17
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 15
- 235000019506 cigar Nutrition 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000010931 gold Substances 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 186
- 230000012010 growth Effects 0.000 abstract description 116
- 102000040430 polynucleotide Human genes 0.000 description 166
- 108091033319 polynucleotide Proteins 0.000 description 166
- 239000002157 polynucleotide Substances 0.000 description 166
- 230000014509 gene expression Effects 0.000 description 117
- 210000004027 cell Anatomy 0.000 description 98
- 239000013598 vector Substances 0.000 description 97
- 239000002679 microRNA Substances 0.000 description 87
- 108700011259 MicroRNAs Proteins 0.000 description 84
- 108020004511 Recombinant DNA Proteins 0.000 description 73
- 239000002773 nucleotide Substances 0.000 description 73
- 125000003729 nucleotide group Chemical group 0.000 description 73
- 230000009466 transformation Effects 0.000 description 65
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 63
- 229930192334 Auxin Natural products 0.000 description 62
- 239000002363 auxin Substances 0.000 description 62
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 60
- 230000006870 function Effects 0.000 description 55
- 230000035772 mutation Effects 0.000 description 50
- 239000012634 fragment Substances 0.000 description 49
- 102000004169 proteins and genes Human genes 0.000 description 49
- 235000018102 proteins Nutrition 0.000 description 46
- 108091027963 non-coding RNA Proteins 0.000 description 44
- 102000042567 non-coding RNA Human genes 0.000 description 44
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 43
- 102000039446 nucleic acids Human genes 0.000 description 42
- 108020004707 nucleic acids Proteins 0.000 description 42
- 210000001519 tissue Anatomy 0.000 description 42
- 238000010459 TALEN Methods 0.000 description 39
- 108020004414 DNA Proteins 0.000 description 36
- 230000002401 inhibitory effect Effects 0.000 description 33
- 230000001105 regulatory effect Effects 0.000 description 32
- 230000002093 peripheral effect Effects 0.000 description 30
- 108091070501 miRNA Proteins 0.000 description 29
- 230000015572 biosynthetic process Effects 0.000 description 28
- 230000027455 binding Effects 0.000 description 25
- 231100000350 mutagenesis Toxicity 0.000 description 25
- 239000000126 substance Substances 0.000 description 25
- 108010078791 Carrier Proteins Proteins 0.000 description 24
- 230000000694 effects Effects 0.000 description 24
- 239000013612 plasmid Substances 0.000 description 24
- 238000011161 development Methods 0.000 description 23
- 230000009368 gene silencing by RNA Effects 0.000 description 23
- 238000002703 mutagenesis Methods 0.000 description 23
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 22
- 230000018109 developmental process Effects 0.000 description 22
- 239000000047 product Substances 0.000 description 22
- 101710163270 Nuclease Proteins 0.000 description 21
- 230000001939 inductive effect Effects 0.000 description 20
- 230000001131 transforming effect Effects 0.000 description 19
- 108010017070 Zinc Finger Nucleases Proteins 0.000 description 18
- 230000005764 inhibitory process Effects 0.000 description 18
- 206010021929 Infertility male Diseases 0.000 description 17
- 208000007466 Male Infertility Diseases 0.000 description 17
- 108091033409 CRISPR Proteins 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 16
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 15
- 239000002609 medium Substances 0.000 description 15
- 210000001938 protoplast Anatomy 0.000 description 15
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 14
- 230000028446 budding cell bud growth Effects 0.000 description 14
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 14
- 229960002715 nicotine Drugs 0.000 description 14
- 241000589158 Agrobacterium Species 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 238000009395 breeding Methods 0.000 description 13
- 230000001488 breeding effect Effects 0.000 description 13
- 230000030833 cell death Effects 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 13
- 230000001404 mediated effect Effects 0.000 description 13
- 230000033228 biological regulation Effects 0.000 description 12
- 238000003776 cleavage reaction Methods 0.000 description 12
- 230000009467 reduction Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 241000894007 species Species 0.000 description 12
- 108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 11
- 230000001276 controlling effect Effects 0.000 description 11
- 230000004568 DNA-binding Effects 0.000 description 10
- 230000000295 complement effect Effects 0.000 description 10
- 238000003780 insertion Methods 0.000 description 10
- 230000037431 insertion Effects 0.000 description 10
- 230000007017 scission Effects 0.000 description 10
- 238000010186 staining Methods 0.000 description 10
- 230000008685 targeting Effects 0.000 description 10
- KUUVQVSHGLHAKZ-UHFFFAOYSA-N thionine Chemical compound C=1C=CC=CSC=CC=1 KUUVQVSHGLHAKZ-UHFFFAOYSA-N 0.000 description 10
- 238000013518 transcription Methods 0.000 description 10
- 230000035897 transcription Effects 0.000 description 10
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 9
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 9
- 102000035195 Peptidases Human genes 0.000 description 9
- 108091005804 Peptidases Proteins 0.000 description 9
- 108020004566 Transfer RNA Proteins 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 239000005090 green fluorescent protein Substances 0.000 description 9
- 230000017653 meristem maintenance Effects 0.000 description 9
- 210000000056 organ Anatomy 0.000 description 9
- 235000000346 sugar Nutrition 0.000 description 9
- 230000009261 transgenic effect Effects 0.000 description 9
- 108010016529 Bacillus amyloliquefaciens ribonuclease Proteins 0.000 description 8
- 238000010443 CRISPR/Cpf1 gene editing Methods 0.000 description 8
- 239000004365 Protease Substances 0.000 description 8
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 8
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 8
- 230000009418 agronomic effect Effects 0.000 description 8
- 150000001413 amino acids Chemical group 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- JKLNYGDWYRKFKR-UHFFFAOYSA-N ethyl methyl sulfate Chemical compound CCOS(=O)(=O)OC JKLNYGDWYRKFKR-UHFFFAOYSA-N 0.000 description 8
- 230000002068 genetic effect Effects 0.000 description 8
- -1 neonicotinoid) Chemical compound 0.000 description 8
- 238000003752 polymerase chain reaction Methods 0.000 description 8
- 239000002243 precursor Substances 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 238000011144 upstream manufacturing Methods 0.000 description 8
- 108700028369 Alleles Proteins 0.000 description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 7
- 239000004062 cytokinin Substances 0.000 description 7
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 7
- 238000012217 deletion Methods 0.000 description 7
- 230000037430 deletion Effects 0.000 description 7
- 238000010362 genome editing Methods 0.000 description 7
- 238000002744 homologous recombination Methods 0.000 description 7
- 230000006801 homologous recombination Effects 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 230000000670 limiting effect Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 230000002018 overexpression Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 239000002689 soil Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 6
- 108010083644 Ribonucleases Proteins 0.000 description 6
- 102000006382 Ribonucleases Human genes 0.000 description 6
- 108091027967 Small hairpin RNA Proteins 0.000 description 6
- 108020004459 Small interfering RNA Proteins 0.000 description 6
- 125000000539 amino acid group Chemical group 0.000 description 6
- 239000000945 filler Substances 0.000 description 6
- 230000006780 non-homologous end joining Effects 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- 230000000306 recurrent effect Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 241000219194 Arabidopsis Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 5
- 108020005004 Guide RNA Proteins 0.000 description 5
- 108091092195 Intron Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 230000030279 gene silencing Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- 239000000123 paper Substances 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000011426 transformation method Methods 0.000 description 5
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 108700004850 Arabidopsis BRC1 Proteins 0.000 description 4
- 108091032955 Bacterial small RNA Proteins 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 102000053187 Glucuronidase Human genes 0.000 description 4
- 108010060309 Glucuronidase Proteins 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 108700009124 Transcription Initiation Site Proteins 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine group Chemical group [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(N)=NC=NC12 OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 210000002257 embryonic structure Anatomy 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 239000003862 glucocorticoid Substances 0.000 description 4
- 238000010884 ion-beam technique Methods 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 230000003007 single stranded DNA break Effects 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 241000219195 Arabidopsis thaliana Species 0.000 description 3
- 108091079001 CRISPR RNA Proteins 0.000 description 3
- 101100437861 Caenorhabditis elegans brc-1 gene Proteins 0.000 description 3
- 241001515826 Cassava vein mosaic virus Species 0.000 description 3
- 108010005843 Cysteine Proteases Proteins 0.000 description 3
- 102000005927 Cysteine Proteases Human genes 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 239000001653 FEMA 3120 Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108700001094 Plant Genes Proteins 0.000 description 3
- 239000013614 RNA sample Substances 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 108020000999 Viral RNA Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 235000004552 Yucca aloifolia Nutrition 0.000 description 3
- 235000012044 Yucca brevifolia Nutrition 0.000 description 3
- 235000017049 Yucca glauca Nutrition 0.000 description 3
- 240000005780 Yucca gloriosa Species 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 238000003782 apoptosis assay Methods 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000008436 biogenesis Effects 0.000 description 3
- 230000015709 bud dormancy process Effects 0.000 description 3
- 239000004927 clay Substances 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 230000000442 meristematic effect Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 229940023486 oral product Drugs 0.000 description 3
- 239000013588 oral product Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 108091007428 primary miRNA Proteins 0.000 description 3
- 230000005522 programmed cell death Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 230000005070 ripening Effects 0.000 description 3
- 230000010153 self-pollination Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 210000003934 vacuole Anatomy 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- MYKUKUCHPMASKF-VIFPVBQESA-N (S)-nornicotine Chemical compound C1CCN[C@@H]1C1=CC=CN=C1 MYKUKUCHPMASKF-VIFPVBQESA-N 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 101100167643 Arabidopsis thaliana CLV3 gene Proteins 0.000 description 2
- 101100206185 Arabidopsis thaliana TCP18 gene Proteins 0.000 description 2
- 101100206195 Arabidopsis thaliana TCP2 gene Proteins 0.000 description 2
- 108091026821 Artificial microRNA Proteins 0.000 description 2
- 102000035101 Aspartic proteases Human genes 0.000 description 2
- 108091005502 Aspartic proteases Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 241000193388 Bacillus thuringiensis Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 108010076667 Caspases Proteins 0.000 description 2
- 102000011727 Caspases Human genes 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108091060290 Chromatid Proteins 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 206010053759 Growth retardation Diseases 0.000 description 2
- 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 2
- 101001023359 Homo sapiens Lung adenoma susceptibility protein 2 Proteins 0.000 description 2
- 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 description 2
- 101001132674 Homo sapiens Retina and anterior neural fold homeobox protein 2 Proteins 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 108010025815 Kanamycin Kinase Proteins 0.000 description 2
- 102100035138 Lung adenoma susceptibility protein 2 Human genes 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 description 2
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 2
- PWHVEHULNLETOV-UHFFFAOYSA-N Nic-1 Natural products C12OC2C2(O)CC=CC(=O)C2(C)C(CCC2=C3)C1C2=CC=C3C(C)C1OC(O)C2(C)OC2(C)C1 PWHVEHULNLETOV-UHFFFAOYSA-N 0.000 description 2
- MYKUKUCHPMASKF-UHFFFAOYSA-N Nornicotine Natural products C1CCNC1C1=CC=CN=C1 MYKUKUCHPMASKF-UHFFFAOYSA-N 0.000 description 2
- 240000004713 Pisum sativum Species 0.000 description 2
- 235000010582 Pisum sativum Nutrition 0.000 description 2
- 241000589615 Pseudomonas syringae Species 0.000 description 2
- 101001023863 Rattus norvegicus Glucocorticoid receptor Proteins 0.000 description 2
- 102100033908 Retina and anterior neural fold homeobox protein 2 Human genes 0.000 description 2
- 108010057163 Ribonuclease III Proteins 0.000 description 2
- 102000003661 Ribonuclease III Human genes 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 101100004651 Schizosaccharomyces pombe (strain 972 / ATCC 24843) brc1 gene Proteins 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- 241000589634 Xanthomonas Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 210000004507 artificial chromosome Anatomy 0.000 description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000036953 caspase-like activity Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000012707 chemical precursor Substances 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 210000003763 chloroplast Anatomy 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000002485 combustion reaction Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 description 2
- 108010088245 cytokinin oxidase Proteins 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 230000005059 dormancy Effects 0.000 description 2
- 230000005782 double-strand break Effects 0.000 description 2
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000013020 embryo development Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- NHGVZTMBVDFPHJ-UHFFFAOYSA-N formyl fluoride Chemical compound FC=O NHGVZTMBVDFPHJ-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- 231100000001 growth retardation Toxicity 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000020169 heat generation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 108010002685 hygromycin-B kinase Proteins 0.000 description 2
- 238000001114 immunoprecipitation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 229940049920 malate Drugs 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- GWWNCLHJCFNTJA-UHFFFAOYSA-N nicandrenone-2 Natural products C12OC2C2(O)CC=CC(=O)C2(C)C(CCC23C)C1C3CCC2(O)C(C)C1OC(O)C2(C)OC2(C)C1 GWWNCLHJCFNTJA-UHFFFAOYSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000005305 organ development Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000000361 pesticidal effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000002708 random mutagenesis Methods 0.000 description 2
- 230000005849 recognition of pollen Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 description 1
- ZQVJBRJGDVZANE-MXDMHAPNSA-N (2s)-2-[(3s,6s,9z,12s,15s,18s,21r,24r,27s)-18,21-bis(2-aminoethyl)-12-benzyl-3-[(1s)-2-chloro-1-hydroxyethyl]-15-[3-(diaminomethylideneamino)propyl]-9-ethylidene-27-[[(3s)-3-hydroxydodecanoyl]amino]-24-(hydroxymethyl)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa Chemical compound N1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCN)NC(=O)[C@@H](CCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](O)CCCCCCCCC)COC(=O)[C@H]([C@H](O)CCl)NC(=O)[C@H]([C@H](O)C(O)=O)NC(=O)\C(=C\C)NC(=O)[C@@H]1CC1=CC=CC=C1 ZQVJBRJGDVZANE-MXDMHAPNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- 229940087195 2,4-dichlorophenoxyacetate Drugs 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical class O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 1
- 102100036826 Aldehyde oxidase Human genes 0.000 description 1
- 101710131969 Aldehyde oxidase 1 Proteins 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 240000001436 Antirrhinum majus Species 0.000 description 1
- 108700009833 Arabidopsis LAS Proteins 0.000 description 1
- 108700039610 Arabidopsis STM Proteins 0.000 description 1
- 101100167641 Arabidopsis thaliana CLV1 gene Proteins 0.000 description 1
- 101100167642 Arabidopsis thaliana CLV2 gene Proteins 0.000 description 1
- 101001119764 Arabidopsis thaliana Disease resistance protein RPS5 Proteins 0.000 description 1
- 101100129499 Arabidopsis thaliana MAX2 gene Proteins 0.000 description 1
- 101100259716 Arabidopsis thaliana TAA1 gene Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 102000008682 Argonaute Proteins Human genes 0.000 description 1
- 108010088141 Argonaute Proteins Proteins 0.000 description 1
- BHELIUBJHYAEDK-OAIUPTLZSA-N Aspoxicillin Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3[C@H](C(C)(C)S[C@@H]32)C(O)=O)=O)NC(=O)[C@H](N)CC(=O)NC)=CC=C(O)C=C1 BHELIUBJHYAEDK-OAIUPTLZSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 241001256373 Clematis crispa Species 0.000 description 1
- FMGBNISRFNDECK-CZSBRECXSA-N Coronatine Chemical compound CC[C@H]1C[C@]1(C(O)=O)NC(=O)C1=C[C@H](CC)C[C@@H]2C(=O)CC[C@H]12 FMGBNISRFNDECK-CZSBRECXSA-N 0.000 description 1
- 241001623626 Corydalis aurea Species 0.000 description 1
- 101710151559 Crystal protein Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
- 239000005976 Ethephon Substances 0.000 description 1
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 101100532389 Gallus gallus RX1 gene Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 241000482313 Globodera ellingtonae Species 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 101150021904 HMGB1 gene Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000907337 Homo sapiens Dynein axonemal intermediate chain 7 Proteins 0.000 description 1
- 101000780650 Homo sapiens Protein argonaute-1 Proteins 0.000 description 1
- 101001008515 Homo sapiens Ribosomal biogenesis protein LAS1L Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 101100235061 Hordeum vulgare HVA1 gene Proteins 0.000 description 1
- 101100396051 Hordeum vulgare HVA22 gene Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 102100029408 Interferon-inducible double-stranded RNA-dependent protein kinase activator A Human genes 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 102100021174 Lipoyl synthase, mitochondrial Human genes 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 239000005983 Maleic hydrazide Substances 0.000 description 1
- BGRDGMRNKXEXQD-UHFFFAOYSA-N Maleic hydrazide Chemical compound OC1=CC=C(O)N=N1 BGRDGMRNKXEXQD-UHFFFAOYSA-N 0.000 description 1
- 241001503485 Mammuthus Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108091030146 MiRBase Proteins 0.000 description 1
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 1
- 101710166115 Mitogen-activated protein kinase 2 Proteins 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 101100327480 Nicotiana tabacum CET2 gene Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 231100000742 Plant toxin Toxicity 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 102100034183 Protein argonaute-1 Human genes 0.000 description 1
- 101150116803 RAX gene Proteins 0.000 description 1
- 101150083007 RAX1 gene Proteins 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 108090000621 Ribonuclease P Proteins 0.000 description 1
- 102000004167 Ribonuclease P Human genes 0.000 description 1
- 102100027433 Ribosomal biogenesis protein LAS1L Human genes 0.000 description 1
- 101150076721 STIG1 gene Proteins 0.000 description 1
- 101100206899 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) TIR2 gene Proteins 0.000 description 1
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 101000953909 Streptomyces viridifaciens Isobutylamine N-hydroxylase Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- ZQVJBRJGDVZANE-UHFFFAOYSA-N Syringomycin Natural products N1C(=O)C(CCCN=C(N)N)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CO)NC(=O)C(NC(=O)CC(O)CCCCCCCCC)COC(=O)C(C(O)CCl)NC(=O)C(C(O)C(O)=O)NC(=O)C(=CC)NC(=O)C1CC1=CC=CC=C1 ZQVJBRJGDVZANE-UHFFFAOYSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 108010015382 Tryptophan transaminase Proteins 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 101150077913 VIP3 gene Proteins 0.000 description 1
- 241000510764 Villosa Species 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 210000005006 adaptive immune system Anatomy 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 101150038500 cas9 gene Proteins 0.000 description 1
- 108020001778 catalytic domains Proteins 0.000 description 1
- 108700021031 cdc Genes Proteins 0.000 description 1
- 238000012832 cell culture technique Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000000701 chemical imaging Methods 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- FMGBNISRFNDECK-UHFFFAOYSA-N coronatine Natural products CCC1CC1(C(O)=O)NC(=O)C1=CC(CC)CC2C(=O)CCC12 FMGBNISRFNDECK-UHFFFAOYSA-N 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000009025 developmental regulation Effects 0.000 description 1
- MOUNHKKCIGVIDI-UHFFFAOYSA-L disodium;4-hydroxy-7-[(5-hydroxy-7-sulfonatonaphthalen-2-yl)carbamoylamino]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC2=CC(NC(=O)NC=3C=C4C=C(C=C(C4=CC=3)O)S([O-])(=O)=O)=CC=C21 MOUNHKKCIGVIDI-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010981 drying operation Methods 0.000 description 1
- 235000005489 dwarf bean Nutrition 0.000 description 1
- UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 239000003571 electronic cigarette Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 244000037666 field crops Species 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000008124 floral development Effects 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000003208 gene overexpression Methods 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 102000054766 genetic haplotypes Human genes 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 108010056100 indole-3-acetamide hydrolase Proteins 0.000 description 1
- 239000003617 indole-3-acetic acid Substances 0.000 description 1
- 108010079535 indoleacetamide hydrolase Proteins 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000012966 insertion method Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000020429 meristem development Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 108091007426 microRNA precursor Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000023409 microsporogenesis Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000032965 negative regulation of cell volume Effects 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 229930000184 phytotoxin Natural products 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 239000003123 plant toxin Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
- 239000000276 potassium ferrocyanide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- PSIKPHJLTVSQFO-UHFFFAOYSA-N propanedihydrazide Chemical compound NNC(=O)CC(=O)NN PSIKPHJLTVSQFO-UHFFFAOYSA-N 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 230000001007 puffing effect Effects 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 108090000446 ribonuclease T(2) Proteins 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 101150007711 rps5 gene Proteins 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000007226 seed germination Effects 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000011869 shoot development Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- YEENEYXBHNNNGV-XEHWZWQGSA-M sodium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoate;(2r,3r,4s,5s,6r)-2-[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound [Na+].CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I.O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YEENEYXBHNNNGV-XEHWZWQGSA-M 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 108010078552 syringomycin Proteins 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 101150065461 tabA gene Proteins 0.000 description 1
- 101150049158 tblA gene Proteins 0.000 description 1
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000012090 tissue culture technique Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012250 transgenic expression Methods 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
- C12N15/827—Flower development or morphology, e.g. flowering promoting factor [FPF]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307035P | 2016-03-11 | 2016-03-11 | |
| US62/307,035 | 2016-03-11 | ||
| US201662399181P | 2016-09-23 | 2016-09-23 | |
| US62/399,181 | 2016-09-23 | ||
| CN201780028908.5A CN109715810B (zh) | 2016-03-11 | 2017-03-13 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
| PCT/US2017/022156 WO2017156535A1 (en) | 2016-03-11 | 2017-03-13 | Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780028908.5A Division CN109715810B (zh) | 2016-03-11 | 2017-03-13 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117126815A true CN117126815A (zh) | 2023-11-28 |
Family
ID=58448614
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310853662.2A Pending CN117126815A (zh) | 2016-03-11 | 2017-03-13 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
| CN201780028908.5A Active CN109715810B (zh) | 2016-03-11 | 2017-03-13 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
| CN202310852150.4A Pending CN117089526A (zh) | 2016-03-11 | 2017-03-13 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
| CN202310851781.4A Pending CN117089525A (zh) | 2016-03-11 | 2017-03-13 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780028908.5A Active CN109715810B (zh) | 2016-03-11 | 2017-03-13 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
| CN202310852150.4A Pending CN117089526A (zh) | 2016-03-11 | 2017-03-13 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
| CN202310851781.4A Pending CN117089525A (zh) | 2016-03-11 | 2017-03-13 | 用于生产烟杈减少或消除的烟草植物和制品的组合物和方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US10731173B2 (enExample) |
| EP (1) | EP3426786A1 (enExample) |
| JP (2) | JP7015243B2 (enExample) |
| CN (4) | CN117126815A (enExample) |
| WO (1) | WO2017156535A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113652416A (zh) * | 2014-10-06 | 2021-11-16 | 奥驰亚客户服务有限公司 | 烟草植物中腋芽生长的遗传控制 |
| EP3426786A1 (en) | 2016-03-11 | 2019-01-16 | Altria Client Services LLC | Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers |
| JP6967217B2 (ja) | 2016-05-13 | 2021-11-17 | 株式会社カネカ | 形質転換植物の作製方法 |
| US11499158B2 (en) | 2016-05-13 | 2022-11-15 | Kaneka Corporation | Method for modifying plant |
| CN109153988B (zh) * | 2016-05-13 | 2023-04-18 | 株式会社钟化 | 植物的基因组编辑方法 |
| WO2019051232A1 (en) | 2017-09-11 | 2019-03-14 | Altria Client Services Llc | COMPOSITIONS AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING REDUCED OR ELIMINATED GOURMETS |
| US11578334B2 (en) * | 2017-10-25 | 2023-02-14 | Monsanto Technology Llc | Targeted endonuclease activity of the RNA-guided endonuclease CasX in eukaryotes |
| CN112714792B (zh) * | 2018-08-02 | 2024-10-22 | 奥驰亚客户服务有限公司 | 经优化的组织优选性启动子和其用途 |
| EP3975694A1 (en) | 2019-05-29 | 2022-04-06 | Altria Client Services LLC | Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers |
| WO2021113337A1 (en) * | 2019-12-03 | 2021-06-10 | Altria Client Services Llc | Compositions and methods for producing tobacco plants and products having altered alkaloid levels |
| CN111560389B (zh) * | 2020-06-11 | 2022-07-01 | 云南中烟工业有限责任公司 | 烟草丝裂原活化蛋白激酶基因NtMAPK8及其应用 |
| CN112522308B (zh) * | 2020-12-15 | 2022-04-01 | 山东农业大学 | 拟南芥tir2基因在提高植物盐胁迫抗性中的应用 |
| CN113393174A (zh) * | 2021-07-22 | 2021-09-14 | 浙江中烟工业有限责任公司 | 一种基于关键指标调查测量的烟叶生产过程跟踪方法及其应用 |
| CN113278729B (zh) * | 2021-07-26 | 2021-10-01 | 广东省农业科学院作物研究所 | 一种烟草青枯病的snp分子标记、其获得方法及其应用 |
| US20250086782A1 (en) * | 2023-09-07 | 2025-03-13 | Altria Client Services Llc | Methods of tobacco classification via hyperspectral imaging |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US76269A (en) * | 1868-03-31 | oscab taber | ||
| US4091823A (en) | 1976-07-12 | 1978-05-30 | Liggett Group Inc. | Cyclogeraniol and derivatives thereof as tobacco flavorants |
| US4762785A (en) | 1982-08-12 | 1988-08-09 | Calgene, Inc. | Novel method and compositions for introducting alien DNA in vivo |
| US4528993A (en) | 1982-08-20 | 1985-07-16 | R. J. Reynolds Tobacco Company | Process for producing moist snuff |
| US4660577A (en) | 1982-08-20 | 1987-04-28 | R.J. Reynolds Tobacco Company | Dry pre-mix for moist snuff |
| US4516590A (en) | 1982-11-26 | 1985-05-14 | Philip Morris Incorporated | Air-cured bright tobacco filler, blends and smoking articles |
| NL8300698A (nl) | 1983-02-24 | 1984-09-17 | Univ Leiden | Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten. |
| US4732856A (en) | 1984-04-03 | 1988-03-22 | Carnegie Institution Of Washington | Transposable elements and process for using same |
| US5231019A (en) | 1984-05-11 | 1993-07-27 | Ciba-Geigy Corporation | Transformation of hereditary material of plants |
| US5149645A (en) | 1984-06-04 | 1992-09-22 | Rijksuniversiteit Leiden | Process for introducing foreign DNA into the genome of plants |
| US4678904A (en) | 1984-07-06 | 1987-07-07 | Technology Dynamics, Inc. | Optical measuring device using a spectral modulation sensor having an optically resonant structure |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US4638816A (en) | 1985-03-22 | 1987-01-27 | Philip Morris Incorporated | Smoking compositions containing a glycosylamine flavorant additive |
| US5188958A (en) | 1986-05-29 | 1993-02-23 | Calgene, Inc. | Transformation and foreign gene expression in brassica species |
| US5177010A (en) | 1986-06-30 | 1993-01-05 | University Of Toledo | Process for transforming corn and the products thereof |
| SE455438B (sv) | 1986-11-24 | 1988-07-11 | Aga Ab | Sett att senka en brennares flamtemperatur samt brennare med munstycken for oxygen resp brensle |
| US5004863B2 (en) | 1986-12-03 | 2000-10-17 | Agracetus | Genetic engineering of cotton plants and lines |
| US4848373A (en) | 1987-04-13 | 1989-07-18 | Helme Tobacco Company | Nicotine removal process and product produced thereby |
| US5316931A (en) | 1988-02-26 | 1994-05-31 | Biosource Genetics Corp. | Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes |
| US5085325A (en) | 1988-03-08 | 1992-02-04 | Simco/Ramic Corporation | Color sorting system and method |
| US5013658A (en) | 1988-05-13 | 1991-05-07 | Dna Plant Technology Corporation | Transposon tagging of genes in transformed plants |
| US5990387A (en) | 1988-06-10 | 1999-11-23 | Pioneer Hi-Bred International, Inc. | Stable transformation of plant cells |
| US4987907A (en) | 1988-06-29 | 1991-01-29 | Helme Tobacco Company | Chewing tobacco composition and process for producing same |
| US5879918A (en) | 1989-05-12 | 1999-03-09 | Pioneer Hi-Bred International, Inc. | Pretreatment of microprojectiles prior to using in a particle gun |
| US5141131A (en) | 1989-06-30 | 1992-08-25 | Dowelanco | Method and apparatus for the acceleration of a propellable matter |
| US5932782A (en) | 1990-11-14 | 1999-08-03 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species adhered to microprojectiles |
| US5372149A (en) | 1992-03-25 | 1994-12-13 | Roth; David S. | Sterilization process in the manufacturing of snuff |
| WO1994002620A2 (en) | 1992-07-27 | 1994-02-03 | Pioneer Hi-Bred International, Inc. | An improved method of agrobacterium-mediated transformation of cultured soybean cells |
| IL108241A (en) | 1992-12-30 | 2000-08-13 | Biosource Genetics Corp | Plant expression system comprising a defective tobamovirus replicon integrated into the plant chromosome and a helper virus |
| US5469976A (en) | 1993-04-30 | 1995-11-28 | Burchell; James R. | Shelf allocation and management system |
| US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
| US5789156A (en) | 1993-06-14 | 1998-08-04 | Basf Ag | Tetracycline-regulated transcriptional inhibitors |
| CN1048254C (zh) | 1993-12-09 | 2000-01-12 | 托马斯杰弗逊大学 | 用于将预定的改变引入靶基因中的化合物 |
| US5491081A (en) | 1994-01-26 | 1996-02-13 | Pioneer Hi-Bred International, Inc. | Soybean cyst nematode resistant soybeans and methods of breeding and identifying resistant plants |
| US5659026A (en) | 1995-03-24 | 1997-08-19 | Pioneer Hi-Bred International | ALS3 promoter |
| US5689035A (en) | 1995-09-26 | 1997-11-18 | Pioneer Hi-Bred International, Inc. | Brown stem rot resistance in soybeans |
| US5731181A (en) | 1996-06-17 | 1998-03-24 | Thomas Jefferson University | Chimeric mutational vectors having non-natural nucleotides |
| US5760012A (en) | 1996-05-01 | 1998-06-02 | Thomas Jefferson University | Methods and compounds for curing diseases caused by mutations |
| US6072050A (en) | 1996-06-11 | 2000-06-06 | Pioneer Hi-Bred International, Inc. | Synthetic promoters |
| DE19631255A1 (de) | 1996-08-02 | 1998-02-05 | Amazonen Werke Dreyer H | Rüttelegge |
| US5880330A (en) * | 1996-08-07 | 1999-03-09 | The Salk Institute For Biological Studies | Shoot meristem specific promoter sequences |
| US5981840A (en) | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
| NZ500694A (en) | 1997-04-30 | 2001-09-28 | Univ Minnesota | Use of chimeric mutational vector (CMV), a macromolecule and a ligand for cell surface receptor adhesion molecule (clatherin) in gene therapy; the CMV vector derived from REC2 homologous pairing with Ustilago maydis |
| EP1007712A4 (en) | 1997-08-05 | 2004-06-30 | Kimeragen Inc | USE OF DUPLEX OLIGONUCLEOTIDES TO AFFECT LOCAL GENETIC CHANGES IN PLANTS |
| CA2310068C (en) | 1997-11-17 | 2008-10-28 | Valmet Corporation | Method for detecting contamination and/or damaging of a face that runs through a nip or nips in a calender for paper |
| US6410872B2 (en) | 1999-03-26 | 2002-06-25 | Key Technology, Inc. | Agricultural article inspection apparatus and method employing spectral manipulation to enhance detection contrast ratio |
| US6646218B1 (en) | 1999-03-29 | 2003-11-11 | Key Technology, Inc. | Multi-band spectral sorting system for light-weight articles |
| ATE309542T1 (de) | 2001-12-04 | 2005-11-15 | Brahms Ag | Verwendung der glycin-n-acyl-transferase (gnat) für die diagnose von entzündungserkrankungen und sepsis |
| US6930492B2 (en) | 2002-08-29 | 2005-08-16 | Malcam Ltd. | Using surface microwaves for measuring and determining density and/or moisture content of a material |
| US7025066B2 (en) | 2002-10-31 | 2006-04-11 | Jerry Wayne Lawson | Method of reducing the sucrose ester concentration of a tobacco mixture |
| US20040118422A1 (en) | 2002-12-19 | 2004-06-24 | Swedish Match North Europe Ab | Tobacco dough and a method for its manufacture |
| US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
| US7694686B2 (en) | 2003-12-22 | 2010-04-13 | U.S. Smokeless Tobacco Company | Conditioning process for tobacco and/or snuff compositions |
| GB0421598D0 (en) * | 2004-09-29 | 2004-10-27 | Cambridge Advanced Tech | Modification of plant development and morphology |
| CN1824774B (zh) * | 2004-11-12 | 2010-05-05 | 贾朝钧 | 一种打顶后无腋芽烟草的培育方法 |
| US20060200878A1 (en) | 2004-12-21 | 2006-09-07 | Linda Lutfiyya | Recombinant DNA constructs and methods for controlling gene expression |
| WO2006091194A1 (en) | 2005-02-23 | 2006-08-31 | North Carolina State University | Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| US8301890B2 (en) | 2006-08-10 | 2012-10-30 | Inside Secure | Software execution randomization |
| AU2007352460C1 (en) | 2006-10-12 | 2013-05-23 | Monsanto Technology, Llc | Plant microRNAs and methods of use thereof |
| US8319011B2 (en) | 2006-12-15 | 2012-11-27 | U.S. Smokeless Tobacco Company Llc | Tobacco plants having reduced nicotine demethylase activity |
| US8124851B2 (en) | 2007-11-12 | 2012-02-28 | North Carolina State University | Alteration of tobacco alkaloid content through modification of specific cytochrome P450 genes |
| ES2351009B1 (es) * | 2009-01-13 | 2012-01-23 | Consejo Superior De Investigaciones Científicas (Csic) | Genes reguladores de la ramificación de plantas, promotores, construcciones genéticas que los contienen y usos. |
| US8953158B2 (en) | 2009-09-04 | 2015-02-10 | Danny S. Moshe | Grading of agricultural products via hyper spectral imaging and analysis |
| CN102858983B (zh) | 2010-01-15 | 2015-08-12 | 北卡罗来纳州立大学 | 最小化烟草中去甲烟碱合成的组合物和方法 |
| KR102253223B1 (ko) * | 2012-12-21 | 2021-05-21 | 필립모리스 프로덕츠 에스.에이. | 식물 내 담배 특이 니트로사민 감소 |
| CN104086637B (zh) * | 2014-07-04 | 2017-04-19 | 西南大学 | 烟草独脚金内酯转运蛋白NtPDR6及其干扰表达载体和应用 |
| CN113652416A (zh) * | 2014-10-06 | 2021-11-16 | 奥驰亚客户服务有限公司 | 烟草植物中腋芽生长的遗传控制 |
| EP3426786A1 (en) | 2016-03-11 | 2019-01-16 | Altria Client Services LLC | Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers |
| CN108247740B (zh) | 2018-01-21 | 2019-07-23 | 成都冠佳科技有限公司 | 无刀痕泡棉胶模切生产方法 |
-
2017
- 2017-03-13 EP EP17714332.8A patent/EP3426786A1/en not_active Withdrawn
- 2017-03-13 WO PCT/US2017/022156 patent/WO2017156535A1/en not_active Ceased
- 2017-03-13 CN CN202310853662.2A patent/CN117126815A/zh active Pending
- 2017-03-13 JP JP2018548130A patent/JP7015243B2/ja active Active
- 2017-03-13 US US15/457,553 patent/US10731173B2/en active Active
- 2017-03-13 CN CN201780028908.5A patent/CN109715810B/zh active Active
- 2017-03-13 CN CN202310852150.4A patent/CN117089526A/zh active Pending
- 2017-03-13 CN CN202310851781.4A patent/CN117089525A/zh active Pending
-
2020
- 2020-06-23 US US16/908,891 patent/US11807860B2/en active Active
-
2022
- 2022-01-21 JP JP2022007548A patent/JP7459150B2/ja active Active
-
2023
- 2023-09-28 US US18/476,495 patent/US12209249B2/en active Active
-
2024
- 2024-12-18 US US18/985,344 patent/US20250129379A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US11807860B2 (en) | 2023-11-07 |
| CN117089525A (zh) | 2023-11-21 |
| JP2022058708A (ja) | 2022-04-12 |
| CN109715810B (zh) | 2023-07-14 |
| WO2017156535A1 (en) | 2017-09-14 |
| US20170260535A1 (en) | 2017-09-14 |
| US20200318129A1 (en) | 2020-10-08 |
| JP2019512247A (ja) | 2019-05-16 |
| US20240035042A1 (en) | 2024-02-01 |
| US10731173B2 (en) | 2020-08-04 |
| EP3426786A1 (en) | 2019-01-16 |
| CN109715810A (zh) | 2019-05-03 |
| JP7459150B2 (ja) | 2024-04-01 |
| JP7015243B2 (ja) | 2022-02-02 |
| CN117089526A (zh) | 2023-11-21 |
| US12209249B2 (en) | 2025-01-28 |
| US20250129379A1 (en) | 2025-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7459150B2 (ja) | 吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法 | |
| JP7399923B2 (ja) | アルカロイドレベル改変タバコ植物体及び製品を作出する組成物及び方法 | |
| JP2025157497A (ja) | タバコ植物を産生するための組成物および方法、ならびに変化したアルカロイドレベルを有する産物 | |
| US12286637B2 (en) | Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers | |
| CN116849114B (zh) | 与烟草中提高的氮利用效率有关的方法和组合物 | |
| CN114981440A (zh) | 用于产生具有改变的生物碱水平的烟草植物和制品的方法及其组合物 | |
| CN116171106A (zh) | 用于生产具有改变的生物碱水平的烟草植物和制品的组合物和方法 | |
| CN114829605A (zh) | 用于通过操纵叶片质量基因生产具有改变的生物碱水平和期望的叶片质量的烟草植物和产品的组合物和方法 | |
| WO2018119124A1 (en) | Compositions and methods for producing tobacco plants and products having altered alkaloid levels | |
| CN114040976A (zh) | 用于产生烟杈减少或消除的烟草植物和产品的组合物和方法 | |
| CN115516098A (zh) | 与改进的氮利用效率有关的方法和组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |